53-44-1

Basic information

• Product Name: 3-{[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxy}propanenitrile
• Synonyms: 3-{[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxy}propanenitrile; MEC
• CAS NO: 53-44-1
• Molecular Formula: C₂₂H₂₉NO₂
• Molecular Weight: 339.4712
• Mol File: 53-44-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 509.1°C at 760 mmHg
• Flash Point: 166.7°C
• Density: 1.11g/cm³
• Vapor Pressure: 1.75E-10mmHg at 25°C
• Refractive Index: 1.559
• CAS DataBase Reference: 3-{[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxy}propanenitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-{[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxy}propanenitrile(53-44-1)
• EPA Substance Registry System: 3-{[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxy}propanenitrile(53-44-1)

Safety Data

• Hazardous Substances Data: 53-44-1(Hazardous Substances Data)

Usage

Description

3-[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxypropanenitrile is a complex chemical compound that features a propanenitrile group connected to a steroid nucleus. This nucleus is a derivative of estratriene, characterized by a methoxy group at position 3, double bonds at positions 1 and 3, and a ketone group at position 17. Its intricate molecular structure endows it with potential pharmaceutical applications, particularly in hormone therapy, due to its estrogenic properties. It may also be valuable in research and development for new drugs or treatments targeting hormonal disorders. The detailed synthesis and characterization of this compound are crucial for comprehending its biological activity and exploring its potential uses in medicine.

Uses

Used in Pharmaceutical Applications:
3-[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxypropanenitrile is utilized as a hormone therapy agent for its estrogenic properties, making it a candidate for the treatment of conditions related to hormonal imbalances.
Used in Research and Development:
In the field of pharmaceutical research and development, 3-[(8xi,9xi,14xi,17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]oxypropanenitrile serves as a key compound for the investigation and creation of new drugs or treatments aimed at hormonal disorders, potentially leading to advancements in medical care.